The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity

Jeremy Dupaul-Chicoine,Azadeh Arabzadeh,Maryse Dagenais,Todd Douglas,Claudia Champagne,Alexandre Morizot,Ian Gaël Rodrigue-Gervais,Valérie Breton,Sara L. Colpitts,Nicole Beauchemin,Maya Saleh,Ian Gaël Rodrigue-Gervais,Sara L. Colpitts

DOI: https://doi.org/10.1016/j.immuni.2015.08.013

IF: 32.4

2015-10-01

Immunity

Abstract:The crosstalk between inflammation and tumorigenesis is now clearly established. However, how inflammation is elicited in the metastatic environment and the corresponding contribution of innate immunity pathways in suppressing tumor growth at secondary sites are poorly understood. Here, we show that mice deficient in Nlrp3 inflammasome components had exacerbated liver colorectal cancer metastatic growth, which was mediated by impaired interleukin-18 (IL-18) signaling. Control of tumor growth was independent of differential cancer cell colonization or proliferation, intestinal microbiota effects, or tumoricidal activity by the adaptive immune system. Instead, the inflammasome-IL-18 pathway impacted maturation of hepatic NK cells, surface expression of the death ligand FasL, and capacity to kill FasL-sensitive tumors. Our results define a regulatory signaling circuit within the innate immune system linking inflammasome activation to effective NK-cell-mediated tumor attack required to suppress colorectal cancer growth in the liver.

immunology